Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C

Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C

Abstract Background Alzheimer´s disease is considered a neurodegenerative disease and is diagnosed by exclusion, while the detection of specific cerebrospinal fluid (CSF) biomarkers, namely amyloid-beta (Aβ) peptides Aβ1–42 (Aß42), phospho-tau (181P; P-tau), and total-tau (T-tau), has been shown to...

ver descrição completa

Detalhes bibliográficos
Principais autores: Franz Felix Konen, Hannah Benedictine Maier, Alexandra Neyazi, Stefan Bleich, Konstantin Neumann, Thomas Skripuletz
Formato: Artigo
Idioma:English
Publicado em: BMC 2023-06-01
coleção:Neurological Research and Practice
Assuntos:
Alzheimer´s disease
Cerebrospinal fluid
Biomarker
Amyloid ß1–42
Phospho-tau
Total-tau
Acesso em linha:https://doi.org/10.1186/s42466-023-00257-5

Internet

https://doi.org/10.1186/s42466-023-00257-5

Registros relacionados